| Literature DB >> 35755299 |
Dalton Borges1,2,3, Mariá C V Nascimento2,3.
Abstract
Recent literature has revealed a growing interest in methods for anticipating the demand for medical items and personnel at hospital, especially during turbulent scenarios such as the COVID-19 pandemic. In times like those, new variables appear and affect the once known demand behavior. This paper investigates the hypothesis that the combined Prophet-LSTM method results in more accurate forecastings for COVID-19 hospital Intensive Care Units (ICUs) demand than both standalone models, Prophet and LSTM (Long Short-Term Memory Neural Network). We also compare the model to well-established demand forecasting benchmarks. The model is tested to a representative Brazilian municipality that serves as a medical reference to other cities within its region. In addition to traditional time series components, such as trend and seasonality, other variables such as the current number of daily COVID-19 cases, vaccination rates, non-pharmaceutical interventions, social isolation index, and regional hospital beds occupation are also used to explain the variations in COVID-19 hospital ICU demand. Results indicate that the proposed method produced Mean Average Errors (MAE) from 13% to 45% lower than well established statistical and machine learning forecasting models, including the standalone models.Entities:
Keywords: Decision support systems; Forecasting; Machine learning; Neural networks; Time series
Year: 2022 PMID: 35755299 PMCID: PMC9212961 DOI: 10.1016/j.asoc.2022.109181
Source DB: PubMed Journal: Appl Soft Comput ISSN: 1568-4946 Impact factor: 8.263
Fig. 1The methodology of the proposed approach.
Fig. 2Target and additional variables used for forecasting.
Vaccine percentage of immunization by doses taken and vaccine maker.
| Vaccine | 1st dose | 2nd dose |
|---|---|---|
| Pfizer | 89% | 92% |
| Coronavac | 42.7% | 86% |
| AstraZeneca | 76% | 81% |
| Janssen | 85.4% | – |
Fig. 3Seasonal pattern.
R-squared improvement with additive and multiplicative seasonalities over the decomposed trend.
| Variable | Additive | Multiplicative |
|---|---|---|
| ICU-in | 2.31% | 2.61% |
| Cases | 5.23% | 6.69% |
| SII | 44.35% | 44.16% |
| RHBO | 0.03% | 0.02% |
| Plano-SP | 0.07% | 0.05% |
| Vax | 0 | 0 |
Optimal time lags and Spearman correlation coefficients (CC) with the target variable.
| Variable | Lag range tested | Optimal lag | CC |
|---|---|---|---|
| Cases | 0–10 days | 0 days | 0.69 |
| SII | 6–16 days | 9 days | −0.07 |
| RHBO | 0–10 days | 0 days | 0.51 |
| Plano-SP | 4–16 days | 6 days | 0.53 |
| Vax | 7–21 days | 19 days | 0.15 |
Fig. 4MAE for feeding forward cross-validation for different Prophet approaches.
Fig. 5Residual analysis after first stage with Prophet.
Fig. 6Target and additional variables used for forecasting.
Comparison of forecasting models.
| Model | Average MAE | MAE CV |
|---|---|---|
| Prophet-LSTM | 0.99 | 0.25 |
| Prophet | 1.16 | 0.22 |
| LSTM | 1.20 | 0.31 |
| GRU | 1.13 | 0.40 |
| Simple RNN | 1.16 | 0.43 |
| Holt-Winters | 1.43 | 0.34 |
| ARIMA | 1.37 | 0.31 |
| KNN | 1.51 | 0.63 |
| RFR | 1.82 | 0.52 |
Fig. 7MAE over time for benchmark models.
Fig. 8MAE over time for benchmark models.